This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
Research Paper Volume 11, Issue 16 pp 5975—5991
LINC00511 promotes the malignant phenotype of clear cell renal cell carcinoma by sponging microRNA-625 and thereby increasing cyclin D1 expression
Figure 7. Silencing of miR-625 expression neutralizes the actions of the LINC00511 knockdown on ccRCC cells. LINC00511-deficient A498 and 786-O cells were treated with either the miR-625 inhibitor or NC inhibitor. Transfected cells were used in the subsequent functional experiments. (A) The expression levels of miR-625 in A498 and 786-O cells after miR-625 inhibitor or NC inhibitor transfection were measured via RT-qPCR. *P < 0.05 vs. the NC inhibitor group. (B, C) miR-625 and CCND1 protein amounts in the above-mentioned cells were determined by RT-qPCR and western blotting, respectively. *P < 0.05 vs. the si-NC group. #P < 0.05 vs. group si-LINC00511+NC inhibitor. (D–I) The proliferation, colony formation, cell cycle status, apoptosis, migration, and invasiveness of A498 and 786-O cells cotransfected with si-LINC00511 and either the miR-625 inhibitor or NC inhibitor were analyzed by the CCK-8 assay, colony formation assay, cell cycle assay, cell apoptosis assay, and Transwell migration and invasion assays, respectively. *P < 0.05 vs. the si-NC group. #P < 0.05 vs. group si-LINC00511+NC inhibitor.